4Tech is a clinical stage medical technology company dedicated to the treatment of tricuspid regurgitation (TR), a common disorder of the right side of the heart.

In order to treat TR, the Company is developing the TriCinch system which enables implanters to perform a safe and easy percutaneous repair of the Tricuspid Valve. The key objectives of the technology are to alleviate pain for the patients and to reduce the health economic burden for the payers.